The Lancet Regional Health - Americas 2022

4 papers
In 2022, research published in *The Lancet Regional Health - Americas* focused extensively on the epidemiological impact and management of the SARS-CoV-2 pandemic across North and South America. A primary theme involved evaluating vaccination outcomes across different demographics, including multi-model studies on the impact of vaccinating children aged 5–11 in the United States and retrospective analyses of severe cases and deaths averted during Brazil's national immunization campaign. These works examined how public health interventions influenced disease burden and resilience to new viral variants. Other research from this period addressed the social and environmental determinants of infection through localized data. Studies utilized population-based serosurveys to identify predictors of serology in vulnerable populations within Rio de Janeiro and applied machine learning techniques to analyze test positivity factors in long-term care homes. Together, these publications highlight a trend toward using diverse analytical methods to understand the regional complexities of the pandemic and the effectiveness of large-scale health interventions throughout the Americas.

Top Research Directions

The 3 research directions with The Lancet Regional Health - Americas 2022 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Model Ensembling for Robustness and Generalization125.0%
2The Evolutionary Dynamics of Viral Immune Evasion125.0%
3Tracking the Long Term Decay of Protective Immunity125.0%

Download all directions as CSV

Institutions

Institutions credited by The Lancet Regional Health - Americas 2022 papers: a paper credits every institution named in its affiliations, once. 18 institutions share 1 credited papers.

#InstitutionPapersShare
1009yjbg58 1100.0%
202xey9a22 1100.0%
3Centers for Disease Control and Prevention 1100.0%
4Columbia University 1100.0%
5Harvard University 1100.0%
6Johns Hopkins University 1100.0%
7Johns Hopkins University Applied Physics Laboratory 1100.0%
8National Institutes of Health 1100.0%
9Pennsylvania State University 1100.0%
10United States Geological Survey 1100.0%
11University of Massachusetts Amherst 1100.0%
12University of North Carolina at Chapel Hill 1100.0%
13University of North Carolina at Charlotte 1100.0%
14University of Notre Dame 1100.0%
15University of Pittsburgh 1100.0%
16University of Southern California 1100.0%
17University of Virginia 1100.0%
18École Polytechnique Fédérale de Lausanne 1100.0%

Download all institutions as CSV

About this data

Papers. The Lancet Regional Health - Americas 2022 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 4 papers (25.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-18 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Lancet Regional Health - Americas 2022”, https://lacuna.tiptreesystems.com/venue/the-lancet-regional-health-americas/2022.

Top Authors

AuthorPapers
Claudio Jose Struchiner2
BO WANG1
Guilherme Tegoni Goedert1
Xuesong Wang1

Papers

Title
Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: a retrospective observational study
Factors associated with SARS-CoV-2 test positivity in long-term care homes: A population-based cohort analysis using machine learning
Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: a multi-model study
Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey